On this page
What is Alcoholic Hepatitis?
Alcoholic hepatitis is an inflammatory condition of the liver caused by chronic, excessive alcohol consumption. It develops in approximately 20 to 30% of heavy drinkers and carries a significant risk of progression to alcoholic cirrhosis, an advanced form of liver scarring, and ultimately chronic liver failure, in which the liver can no longer perform its essential functions.
The condition typically presents with:
- Abdominal pain
- General malaise and fever
- Nausea and vomiting
In severe cases, it progresses to the features of frank liver failure (jaundice, ascites, encephalopathy).
Diagnosis is straightforward when a history of sustained heavy alcohol use is combined with the characteristic clinical and laboratory picture.
The cornerstone of treatment is complete and permanent alcohol abstinence. Corticosteroids (cortisone) may be used to reduce acute hepatic inflammation in selected patients. In end-stage alcoholic cirrhosis, liver transplantation may be the only remaining option.
Prognosis depends on the severity of liver damage and, crucially, whether it is reversible.
Causes
Classification of Alcoholic Liver Disease
Alcoholic hepatitis does not develop in isolation. It is part of a progressive spectrum of alcohol-related liver disease (ARLD) that unfolds in three stages:
-
Alcoholic fatty liver (hepatic steatosis): the earliest and most reversible stage. Excess alcohol metabolism leads to fat accumulation within liver cells (hepatocytes). This is present in virtually all heavy drinkers but is often asymptomatic and fully reversible with abstinence.
-
Alcoholic hepatitis: chronic alcohol toxicity triggers an active inflammatory process within the liver. This stage carries significant morbidity and mortality risk, particularly in severe presentations.
-
Alcoholic cirrhosis: the end stage of alcohol-related liver disease, characterized by irreversible replacement of functional liver tissue with fibrous scar tissue. Cirrhosis can lead to portal hypertension, liver failure, and hepatocellular carcinoma (liver cancer) in some patients.
An important observation regarding sex differences: alcoholic hepatitis is more common in women than in men, despite men drinking more heavily (with a male-to-female ratio of approximately 8:1 in overall alcohol consumption). This paradox is explained by the fact that women express lower levels of alcohol dehydrogenase, the primary liver enzyme responsible for metabolizing and detoxifying alcohol. With less enzymatic capacity, women sustain greater liver damage per gram of alcohol consumed.
Risk Factors
The dominant risk factor is alcohol itself, and two parameters matter most:
- Quantity consumed: determined by both volume and the alcohol content (percentage by volume) of beverages consumed
- Duration of abuse: alcoholic hepatitis typically requires years of heavy drinking to develop
Beyond alcohol consumption itself, additional factors influence individual risk:
- Nutritional status: Malnutrition, which is common among heavy drinkers, significantly amplifies alcohol-related liver toxicity. Deficiencies in protein, vitamins (particularly B vitamins, folate, vitamin E), and minerals impair the liver’s capacity to repair and defend itself.
- Genetic and metabolic background: Variations in genes encoding alcohol-metabolizing enzymes (alcohol dehydrogenase, aldehyde dehydrogenase, CYP2E1) can dramatically alter the rate at which alcohol is broken down into its toxic metabolites, particularly acetaldehyde, the primary mediator of liver damage.
- Obesity: overweight and obesity compound alcohol-related liver damage by adding metabolic stress (non-alcoholic fatty liver disease) to an already compromised organ.
- Concurrent viral hepatitis: co-infection with hepatitis B or C substantially accelerates liver damage and cirrhosis in heavy drinkers.
- Sex (as described above).
How Liver Damage Develops
Understanding the mechanism of injury helps explain why alcoholic hepatitis is both preventable and potentially reversible in its earlier stages.
Alcohol is absorbed from the stomach and small intestine, transported to the liver, and metabolized primarily by the enzyme alcohol dehydrogenase. When alcohol consumption chronically exceeds the liver’s metabolic capacity, the following cascade occurs:
-
Metabolic disruption: the liver’s metabolic machinery becomes overwhelmed, causing a shift toward fat synthesis. Elevated production of triglycerides and fatty acids leads to their accumulation within hepatocytes, producing alcoholic steatosis (fatty liver).
-
Acetaldehyde toxicity: excessive alcohol is metabolized through an alternative pathway (microsomal ethanol-oxidizing system, MEOS), generating acetaldehyde, a highly reactive compound that directly damages hepatocyte proteins, mitochondrial membranes, and DNA.
-
Oxidative stress: alcohol metabolism generates reactive oxygen species (free radicals) that overwhelm the liver’s antioxidant defenses, causing further cellular injury.
-
Inflammatory cascade: damaged hepatocytes release damage-associated molecular patterns (DAMPs) and bacterial lipopolysaccharides (LPS, translocated from a compromised gut barrier) that activate Kupffer cells (the liver’s resident macrophages), triggering the release of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, IL-8). This sustained inflammatory response defines alcoholic hepatitis and drives progressive cell death.
-
Fibrosis and cirrhosis: chronic inflammation activates hepatic stellate cells, which produce excess collagen and fibrous tissue that progressively replaces functional liver parenchyma, leading to irreversible cirrhosis.
Symptoms
The clinical presentation of alcoholic hepatitis ranges from mild and non-specific to life-threatening, depending on the severity and duration of liver damage.
Symptoms of Alcoholic Hepatitis (Pre-Cirrhotic Stage)
- Abdominal pain: typically in the right upper quadrant (over the liver), varying from a dull ache to severe pain
- Fever and general malaise: low-grade fever reflecting hepatic inflammation; profound fatigue and general unwellness
- Nausea and vomiting
- Loss of appetite and weight loss
- Hepatomegaly: an enlarged, tender liver palpable on physical examination
Symptoms of Advanced Alcoholic Cirrhosis and Liver Failure
When disease progresses to cirrhosis and chronic liver failure, far more serious symptoms develop:
- Jaundice: yellowing of the skin, mucous membranes, and whites of the eyes, caused by impaired bilirubin metabolism
- Ascites: abnormal accumulation of fluid within the abdominal cavity, causing significant abdominal distension and resulting from portal hypertension and low serum albumin.
- Abnormal liver function tests: markedly elevated transaminases, bilirubin, and coagulation times.
- Hepatic encephalopathy: brain dysfunction caused by the accumulation of toxins (particularly ammonia) that the failing liver cannot clear. Manifestations include:
- Mental confusion and disorientation.
- Altered consciousness and behavioral changes.
- In severe cases, coma.
- Haemoptysis from variceal bleeding: rupture of dilated esophageal varices (swollen veins caused by portal hypertension) causes vomiting of blood or passage of dark tarry stools, which is a life-threatening emergency.
- Portal hypertension: elevated blood pressure in the portal venous system, driving ascites and variceal formation.
- Coagulopathy: reduced synthesis of clotting factors by the damaged liver leads to easy bruising and abnormal bleeding.
Additionally, chronic heavy alcohol use significantly increases the risk of hepatocellular carcinoma (primary liver cancer), independent of cirrhosis. However, the risk is substantially higher in the cirrhotic liver.
Diagnosis
Diagnosis begins with the clinical history, a frank discussion in which the patient reports a sustained pattern of heavy alcohol consumption over many years. Accurate quantification of alcohol intake (in grams per day or standard drinks per week) is essential to assess the likelihood and severity of alcohol-related liver disease.
Physical Examination
The physician will look for:
- Hepatomegaly (enlarged, tender liver)
- Jaundice
- Spider angiomata (small dilated blood vessels on the skin, a sign of chronic liver disease)
- Palmar erythema (redness of the palms)
- Gynecomastia in men (breast tissue enlargement from impaired estrogen metabolism)
- Ascites and edema
Laboratory Tests
Blood tests reveal characteristic abnormalities:
- Elevated transaminases (liver enzymes): AST and ALT are both raised, but the key diagnostic pattern is that the AST/ALT ratio is greater than 2, which is highly suggestive of alcoholic liver disease. In most other liver diseases, ALT is higher than or equal to AST.
- Elevated bilirubin: proportional to the severity of liver dysfunction
- Elevated gamma-GT (GGT): a sensitive marker of alcohol-related liver damage and a useful indicator of ongoing drinking
- Elevated mean corpuscular volume (MCV): alcohol directly impairs red blood cell production, causing macrocytosis
- Reduced albumin: reflecting impaired hepatic synthetic function in advanced disease
- Prolonged prothrombin time (PT) / elevated INR: impaired coagulation factor synthesis, indicating liver failure
- Complete blood count: may show anemia, leukocytosis (during acute inflammatory episodes), or thrombocytopenia (from portal hypertension and hypersplenism)
Imaging
- Abdominal ultrasound: demonstrates a hyperechoic (bright), enlarged, fatty liver in steatosis; in cirrhosis, shows a nodular, shrunken liver with signs of portal hypertension (splenomegaly, ascites, dilated portal vein).
- CT scan: used to exclude other causes of liver disease, particularly hepatocellular carcinoma, and to evaluate the biliary tract and surrounding structures.
Liver Biopsy
Liver biopsy is rarely required for clinical management but can definitively confirm the histological diagnosis of alcoholic hepatitis when the clinical picture is uncertain. Characteristic histological findings include hepatocyte ballooning (swelling and degeneration), neutrophilic infiltration, Mallory-Denk bodies (intracellular aggregates of damaged cytoskeletal proteins), and, in advanced disease, fibrosis and cirrhosis.
Treatment
1. Complete Alcohol Abstinence: The Essential Foundation
Abstinence from all alcohol is the single most important and effective treatment for alcoholic hepatitis at any stage. The extent of recovery depends on the degree and reversibility of liver damage at the time of abstinence:
- In alcoholic fatty liver (steatosis): significant improvement, often complete resolution, can be seen within one month of abstinence. Fatty liver is largely reversible.
- In alcoholic hepatitis: more prolonged abstinence is required, typically several months, to allow meaningful hepatic repair and recovery.
- In alcoholic cirrhosis: fibrotic damage is irreversible, but abstinence can halt further progression, prevent decompensation, reduce portal hypertension, and significantly improve survival even at this advanced stage.
Achieving abstinence in individuals with alcohol use disorder often requires multidisciplinary support, including:
- Addiction medicine consultation and pharmacological support (naltrexone, acamprosate, disulfiram)
- Psychological counseling and behavioral therapy
- Support groups (Alcoholics Anonymous)
- Social services involvement when appropriate
2. Nutritional Support
Malnutrition is almost universally present in alcoholic hepatitis and independently worsens outcomes. Nutritional rehabilitation is therefore a core therapeutic component:
- High-calorie, high-protein diet: patients should consume approximately 35–40 kcal/kg/day with adequate protein (1.2–1.5 g/kg/day) to support liver regeneration and prevent muscle wasting.
- Vitamin and mineral supplementation: particularly thiamine (B1), which is essential to prevent Wernicke’s encephalopathy; also folate, B12, zinc, and vitamin D.
- Avoidance of nutritional deficiencies that amplify alcohol-induced liver toxicity.
- In patients unable to eat adequately, enteral nutrition via nasogastric tube should be initiated.
3. Corticosteroids
Corticosteroids (prednisolone), which are anti-inflammatory medications, are the primary pharmacological treatment for severe alcoholic hepatitis. This is defined by a Maddrey discriminant function (DF) score of 32 or higher, or a MELD score of 21 or higher. These validated scoring systems estimate short-term mortality and identify patients most likely to benefit from steroid therapy.
Standard treatment is prednisolone 40 mg/day orally for 28 days, followed by a taper. The rationale is to suppress the intense hepatic inflammatory response that drives acute hepatocyte death.
Response to therapy is assessed at 7 days using the Lille score, a mathematical model incorporating bilirubin kinetics. Patients who do not respond to steroids (Lille score ≥0.45) are unlikely to benefit from continuing treatment and have a poor short-term prognosis.
Contraindications to steroids include: active infection (particularly spontaneous bacterial peritonitis or sepsis), gastrointestinal bleeding, renal failure, and uncontrolled diabetes, all common complications of advanced liver disease that must be carefully excluded before initiating steroid therapy.
Pentoxifylline (a TNF-α inhibitor and phosphodiesterase inhibitor) was previously used as an alternative, but recent evidence from the STOPAH trial has questioned its benefit; it is no longer routinely recommended.
4. Liver Transplantation
For patients with end-stage alcoholic cirrhosis or severe alcoholic hepatitis not responding to medical therapy, liver transplantation is the only life-saving option.
Standard transplantation criteria require a minimum of 6 months of documented alcohol abstinence before listing. This serves two purposes: to allow for potential spontaneous hepatic recovery and to demonstrate commitment to sobriety. However, select patients with severe acute alcoholic hepatitis who fail medical treatment may be considered for early transplantation without meeting the 6-month criterion, at specialized centers with established selection protocols.
Absolute prerequisites for transplant candidacy include:
- Documented sustained alcohol abstinence
- Active participation in addiction treatment programs
- Absence of other severe organ dysfunction that would negate the benefit of transplantation
- Adequate psychosocial support and assessed low risk of post-transplant relapse
Sources and Bibliography
- O’Shea RS, et al. ACG Clinical Guideline: Alcoholic Liver Disease. Am J Gastroenterol. 2018;113(2):175–194.
- Alcoholic Liver Disease – ACG Clinical Guideline. LWW Journals.
- Thursz MR, et al. Prednisolone or pentoxifylline for alcoholic hepatitis (STOPAH trial). N Engl J Med. 2015;372(17):1619–1628.
- Singal AK, et al. ACG Clinical Guideline: Alcoholic Liver Disease. Am J Gastroenterol. 2018;113:175–194.
- European Association for the Study of the Liver (EASL). EASL Clinical Practice Guidelines: Management of alcohol-related liver disease. J Hepatol. 2018;69(1):154–181.
